The flu Concept is rising, Shandong Lukang Pharmaceutical has reached its limit up, and ApicHope Pharmaceutical and others are among the top gainers.

On December 20, Gelonghui reported that the A-share influenza concept is experiencing a volatile upward trend, with Shandong Lukang Pharmaceutical hitting the limit up, and Beijing Hotgen Biotech Co., Ltd and Hybio Pharmaceutical rising over 12%. Other stocks such as Yirui Biotech, Chongqing Taiji Industry, ApicHope Pharmaceutical, and Lushang Freda Pharmaceutical also followed suit. In recent news, the China Centers for Disease Control and Prevention released a report on the recent monitoring of respiratory infectious diseases nationwide, indicating a sustained upward trend in acute respiratory infectious diseases, with a significant increase in influenza.

Gelonghui FinanceDec 20 14:13

Eryou Biotechnology (300942.SZ): The company does not rule out enhancing competitiveness through mergers and acquisitions in the future.

Gelonghui, December 4th丨Erye Biological (300942.SZ) stated during an investor relations event that from the perspective of global strategy expansion, the company does not rule out enhancing its competitiveness through mergers and acquisitions, bringing value-added effects to the company and creating more value for shareholders.

Gelonghui FinanceDec 4 15:26

Yirui Biology (300942.SZ): The company has the testing capability for pre-cooked food related products.

Gelonghui on November 29th | Yirui Biology (300942.SZ) stated on the investor interaction platform that the company has the testing capability of pre-cooked food related products, which can achieve high-precision testing of various limited substances in pre-cooked food such as preservatives, veterinary drug residues, pesticide residues, mycotoxins, pathogenic microorganisms, etc., effectively ensuring food safety.

Gelonghui FinanceNov 29 15:03

Express News | Yirui Biosciences: The company's operation is normal.

BreakingsNov 27 18:04

Express News | Yirui Biology and others established a technology company in heilongjiang.

BreakingsNov 22 10:22

Yirui Biology (300942.SZ): The fully automated testing workstations developed have already been adopted by multiple clients in different stages of project implementation.

Gelonghui October 31st | Yirui Biological (300942.SZ) stated at an investor relations event that the company has developed a fully automated detection workstation, which has already been in progress with multiple clients. For example, some Mengniu factories have completed validation, Nestle in Qingdao has completed validation and is in the trial phase. Several clients such as guangdong yantang dairy have expressed purchasing intentions and are in negotiation. The company provides customers with systematic and digital solutions to ensure the quality of testing, help customers achieve digital transformation of quality control and traceability, and reduce costs and increase efficiency; at the same time, considering the compatibility of test reagents, the sales of fully automated detection workstations will continue.

Gelonghui FinanceOct 31 15:20